0:00
43:47
Meta and Microsoft in focus, as the big tech names report results. How our traders are handling the moves, and what it means for entire tech trade. Plus Eli Lilly getting hit, as the pharma stock misses estimates and slashes guidance. So are the disappointing results a sign the weight loss drug boom is slimming out?
D'autres épisodes de "CNBC's "Fast Money""
Ne ratez aucun épisode de “CNBC's "Fast Money"” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.